BioFire Defense develops and manufactures molecular diagnostic products for biological threat detection and infectious disease response. The company's core business centers on syndromic molecular technology, serving customers in biodefense, first responder, government, military, and public health sectors. Its products are designed for use across diverse environments, including point-of-care settings, laboratories, and military deployments.
The company's product portfolio includes the BioFire® FilmArray® and BioFire® SPOTFIRE® systems, as well as the RAZOR® Mk II Systems. These are biological agent identification products built for the biodefense and first responder community. BioFire Defense operates as a cGMP-compliant medical device manufacturer and holds DCAA-audited contractor status, indicating its engagement with U.S. Department of Defense contracts.
BioFire Defense's technical capabilities span laboratory diagnostics, point-of-care diagnostics, and biothreat detection. Its customer base includes government and military facilities, laboratories, and public health settings where rapid identification of biological agents and infectious diseases is critical.
